Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.

Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C.

Inflamm Bowel Dis. 2008 Apr;14(4):566-74. Review.

PMID:
18022872
2.

Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications.

Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C.

Pharmacol Ther. 2008 Dec;120(3):233-53. doi: 10.1016/j.pharmthera.2008.08.010. Epub 2008 Sep 14. Review.

PMID:
18848843
3.

Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.

Blandizzi C.

Neurochem Int. 2007 Oct;51(5):282-8. Epub 2007 Jun 2. Review.

PMID:
17618014
4.

Neuroimmunology of the gut: physiology, pathology, and pharmacology.

Ben-Horin S, Chowers Y.

Curr Opin Pharmacol. 2008 Aug;8(4):490-5. doi: 10.1016/j.coph.2008.07.010. Epub 2008 Aug 20. Review.

PMID:
18675937
5.

Adenosine in the inflamed gut: a Janus faced compound.

Estrela AB, Abraham WR.

Curr Med Chem. 2011;18(18):2791-815. Review.

PMID:
21649583
6.

Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

Motilva V, Talero E, Calvo JR, Villegas I, Alarcón-de-la-Lastra C, Sánchez-Fidalgo S.

Curr Pharm Des. 2008;14(1):71-95. Review.

PMID:
18220820
7.

Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, Blandizzi C, Fornai M.

Curr Drug Targets. 2012 Jun;13(6):842-62. Review.

PMID:
22250650
8.

Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms.

De Schepper HU, De Man JG, Moreels TG, Pelckmans PA, De Winter BY.

Aliment Pharmacol Ther. 2008 Apr;27(8):621-37. doi: 10.1111/j.1365-2036.2008.03624.x. Epub 2008 Jan 23. Review.

9.

Adenosine receptors and inflammation.

Blackburn MR, Vance CO, Morschl E, Wilson CN.

Handb Exp Pharmacol. 2009;(193):215-69. doi: 10.1007/978-3-540-89615-9_8. Review.

PMID:
19639284
10.

Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments.

Hunt RH, Tougas G.

Best Pract Res Clin Gastroenterol. 2002 Dec;16(6):869-83. Review.

PMID:
12473296
11.

The enteric nervous system III: a target for pharmacological treatment.

Hansen MB.

Pharmacol Toxicol. 2003 Jul;93(1):1-13. Review.

PMID:
12828568
12.

Plasticity of the enteric nervous system during intestinal inflammation.

Lomax AE, Fernández E, Sharkey KA.

Neurogastroenterol Motil. 2005 Feb;17(1):4-15. Review.

13.
14.

Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome.

Santos J, Alonso C, Vicario M, Ramos L, Lobo B, Malagelada JR.

Curr Mol Med. 2008 Jun;8(4):258-73. Review.

PMID:
18537634
15.

Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions.

Fornai M, Antonioli L, Colucci R, Bernardini N, Ghisu N, Tuccori M, De Giorgio R, Del Tacca M, Blandizzi C.

Pharmacol Ther. 2010 Jan;125(1):62-78. doi: 10.1016/j.pharmthera.2009.09.007. Epub 2009 Oct 4. Review.

PMID:
19808045
16.

Neuro-glial crosstalk in inflammatory bowel disease.

Neunlist M, Van Landeghem L, Bourreille A, Savidge T.

J Intern Med. 2008 Jun;263(6):577-83. doi: 10.1111/j.1365-2796.2008.01963.x. Review.

17.

Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease (Review).

Baumgart DC, McVay LD, Carding SR.

Int J Mol Med. 1998 Feb;1(2):315-32. Review.

PMID:
9852233
18.

Role of adenosine receptors in the treatment of asthma and chronic obstructive pulmonary disease: recent developments.

van den Berge M, Hylkema MN, Versluis M, Postma DS.

Drugs R D. 2007;8(1):13-23. Review.

PMID:
17249846
19.

Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.

Akkari R, Burbiel JC, Hockemeyer J, Müller CE.

Curr Top Med Chem. 2006;6(13):1375-99. Review.

PMID:
16918456

Supplemental Content

Support Center